You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RIGL Exercise Disclosure
Schorno Dean L · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$27.7K
Schorno Dean L EVP & Chief Financial Officer
RIGL
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
RIGL daily price context
Close on/before transaction
$29.86
Jun 1, 2026
First close after public filing
$30.25
Jun 4, 2026
30-day return after filing
+33.07%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,181 shares @ $12.7
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000905148-26-002811
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$77.85K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rigel Pharmaceuticals Inc RIGL | Exercise | Jun 1, 2026 | $22.44K |
| Rigel Pharmaceuticals Inc RIGL Current | Exercise | Jun 1, 2026 | $27.7K |
| Rigel Pharmaceuticals Inc RIGL | Disposition | Jun 1, 2026 | $27.71K |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Jun 1, 2026 | $0 |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Jun 1, 2026 | $0 |